| http://www.w3.org/ns/prov#value | - ???The accomplishments achieved in 2011, particularly in the last quarter with the launch and positive trajectory of the MaterniT21 LDT, are a reflection of the Company???s dedication to achieving our mission to deliver genetic analysis solutions to improve patient care,??? said Harry F. Hixson, Jr , Ph.D., Chairman and CEO of Sequenom. ???2011 was a year primarily dedicated to reaching our resear
|
